{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:29:25Z","timestamp":1791894565863,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":3648,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1111\/j.1469-0691.2006.01404.x","type":"journal-article","created":{"date-parts":[[2006,3,8]],"date-time":"2006-03-08T09:30:13Z","timestamp":1141810213000},"page":"17-22","source":"Crossref","is-referenced-by-count":42,"special_numbering":"S2","title":["Ceftobiprole: in-vivo profile of a bactericidal cephalosporin"],"prefix":"10.1016","volume":"12","author":[{"given":"H.F.","family":"Chambers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl A","key":"10.1111\/j.1469-0691.2006.01404.x_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jac\/39.suppl_1.53","article-title":"A review of in\u2010vitro antibacterial activity of quinupristin\/dalfopristin against methicillin\u2010susceptible and \u2010resistant Staphylococcus aureus","volume":"39","author":"Low","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/13543784.12.3.379","article-title":"Novel antibacterial agents for the treatment of serious Gram\u2010positive infections","volume":"12","author":"Abbanat","year":"2003","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","author":"National Nosocomial Infections Surveillance System","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2307\/30148460","article-title":"Methicillin\u2010resistant Staphylococcus aureus in US hospitals, 1975\u20131991","volume":"13","author":"Panlilio","year":"1992","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/14728222.9.2.253","article-title":"MRSA\u2014what is it, and how do we deal with the problem?","volume":"9","author":"Barrett","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib6","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1128\/JCM.39.10.3727-3732.2001","article-title":"Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study","volume":"39","author":"Fluit","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3201\/eid1009.040069","article-title":"Methicillin\u2010resistant Staphylococcus aureus in Europe, 1999\u20132002","volume":"10","author":"Tiemersma","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/422458","article-title":"Staphylococcus aureus with reduced susceptibility to vancomycin","volume":"39","author":"Cosgrove","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cll.2004.03.004","article-title":"Vancomycin resistance in Staphylococcus aureus","volume":"24","author":"Appelbaum","year":"2004","journal-title":"Clin Lab Med"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/jac\/dkg457","article-title":"Antibacterial susceptibility of a vancomycin\u2010resistant Staphylococcus aureus strain isolated at the Hershey Medical Center","volume":"52","author":"Bozdogan","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.diagmicrobio.2005.02.015","article-title":"Comparative in vitro activities of daptomycin, linezolid, and quinupristin\/dalfopristin against Gram\u2010positive bacterial isolates from a large cancer center","volume":"52","author":"Smith","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3201\/eid0901.020172","article-title":"Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance","volume":"9","author":"Stratton","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00001432-200412000-00007","article-title":"Recent advances in the treatment of infections due to resistant Staphylococcus aureus","volume":"17","author":"Anstead","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clinthera.2005.01.007","article-title":"Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram\u2010positive organisms","volume":"27","author":"Garrison","year":"2005","journal-title":"Clin Ther"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/AAC.45.3.825-836.2001","article-title":"In vitro and in vivo properties of Ro 63\u20109141, a novel broad\u2010spectrum cephalosporin with activity against methicillin\u2010resistant staphylococci","volume":"45","author":"Hebeisen","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib16","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1128\/AAC.49.10.4210-4219.2005","article-title":"Antistaphylococcal activity of ceftobiprole, a new broad\u2010spectrum cephalosporin","volume":"49","author":"Bogdanovich","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/AAC.46.1.171-177.2002","article-title":"BAL9141, a novel extended\u2010spectrum cephalosporin active against methicillin\u2010resistant Staphylococcus aureus in treatment of experimental endocarditis","volume":"46","author":"Entenza","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib18","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1128\/AAC.48.7.2570-2575.2004","article-title":"Single\u2010dose pharmacokinetics and safety of a novel broad\u2010spectrum cephalosporin (BAL5788) in healthy volunteers","volume":"48","author":"Schmitt\u2010Hoffmann","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib19","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1128\/AAC.48.7.2576-2580.2004","article-title":"Multiple\u2010dose pharmacokinetics and safety of a novel broad\u2010spectrum cephalosporin (BAL5788) in healthy volunteers","volume":"48","author":"Schmitt\u2010Hoffmann","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib20","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1128\/AAC.49.9.3789-3793.2005","article-title":"Intensive therapy with ceftobiprole medocaril of experimental foreign\u2010body infection by methicillin\u2010resistant Staphylococcus aureus","volume":"49","author":"Vaudaux","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib21","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/AAC.49.3.884-888.2005","article-title":"Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin\u2010resistant and vancomycin\u2010intermediate Staphylococcus aureus","volume":"49","author":"Chambers","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jhin.2001.1052","article-title":"Implant infections: a haven for opportunistic bacteria","volume":"49","author":"Schierholz","year":"2001","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/00003495-200565020-00003","article-title":"Infections associated with medical devices: pathogenesis, management and prophylaxis","volume":"65","author":"Von Eiff","year":"2005","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib24","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/AAC.34.12.2312","article-title":"Treatment of experimental foreign body infection caused by methicillin\u2010resistant Staphylococcus aureus","volume":"34","author":"Lucet","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01404.x_bib25","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1046\/j.1469-0691.2003.00765.x","article-title":"Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone\u20103\u2010ylidenemethyl cephem, tested against streptococci, enterococci and methicillin\u2010resistant staphylococci","volume":"9","author":"Deshpande","year":"2003","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15602464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15602464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T03:10:59Z","timestamp":1555470659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15602464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":25,"alternative-id":["S1198743X15602464"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01404.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}